Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
-
Randomized Controlled Trial Controlled Clinical Trial
Pilot study on lower nitrosamine smokeless tobacco products compared with medicinal nicotine.
Smokeless tobacco (ST) products have the potential to be used as a harm reduction method for cigarette smokers. These products can deliver significantly less toxicants than cigarettes, although they are not toxicant free nor harmless. It is important to examine potential health risks and benefits of these products. ⋯ With the exception of medicinal nicotine products, low-nitrosamine ST products have the greatest potential to result in reduced toxicant exposure compared with other combustible reduced exposure products and have promise for reducing individual risk for disease. However, the population effect of marketing of such products as reduced exposure/reduced risk is unknown. The need for further research in this area and regulation of tobacco products is evident.